VRBPAC Meeting to Review Novavax EAU for Adult COVID-19 Vaccine
The FDA VRBPAC will meet in open session on 7 June 2022 to discuss an Emergency Use Authorization (EUA) request by Novavax for a vaccine to prevent COVID-19 in individuals 18 years of age and older. The Food and Drug Administration (FDA) announces a forthcoming public advisory committee meeting of the Vaccines and Related […]